Collegium Pharmaceutical Inc (COLL)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	1,663,590	1,635,150	1,053,390	1,114,250	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793
Total stockholders’ equity	US$ in thousands	1,663,590	234,279	216,583	222,169	195,431	178,873	200,805	179,733	194,842	197,194	197,612	196,076	202,928	251,094	253,066	170,035	186,031	172,686	155,767	141,063
Financial leverage ratio		1.00	6.98	4.86	5.02	5.85	6.58	6.05	6.76	6.03	6.09	6.30	6.36	3.41	2.95	2.82	3.80	3.46	3.73	4.15	4.50

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,663,590K ÷ $1,663,590K
= 1.00

The financial leverage ratio of Collegium Pharmaceutical Inc has shown some fluctuations over the past few years. The ratio was 4.50 as of March 31, 2020, and gradually decreased to 2.82 by June 30, 2021, indicating a reduction in the company's reliance on debt to finance its operations. However, from March 31, 2022, the ratio increased significantly to 6.36 and has generally remained at elevated levels through December 31, 2024, with fluctuations in between. This suggests a notable increase in the company's financial leverage, potentially indicating a higher level of debt relative to equity in its capital structure. It is important for stakeholders to closely monitor Collegium Pharmaceutical Inc's financial leverage ratio to assess its risk exposure and ability to meet its financial obligations in the future.